MULTI BENEFITS: Curbs cravings and supports appetite suppression, balanced sugar levels, metabolism boost and improved immunity and mood
Phase 3 Outlook: Based on Phase 2 results, a Phase 3 trial is planned for the first half of 2025 to evaluate the co-formulated bremelanotide plus PDE5 inhibitor combination in PDE5i non-responders
NAD+ precursors are usually well-tolerated but may rarely cause mild nausea or flushing
This introduces variability in pharmacodynamics, as GLP-1RA penetration into specific brain regions may differ based on sex, compound properties, and age ( This raises important questions for ongoing trials such as EVOKE, which may uncover sex-specific differences and justify subsequent investigations of GLP-1 analogues in female populations
Information about ingredients in medications and nutritional/dietary supplements can be obtained by contacting AXIS at 816-474-7321 or axis.drugfreesport.com (access code ncaa1, ncaa2 or ncaa3).
GLP-1 Dietitian and Nutritionist Our registered dietitian and nutritionist for GLP-1 will provide personalized guidance around its use, provide support along the way and address any related health concerns